Clinical Diagnostics

Selected news for the healthcare topic - Clinical Diagnostics, collected since 10/2017. Recent stories appear in Modern Healthcare and PR Newswire. This healthcare topic shares news with COVID-19, Infectious Disease, COVID-19 Testing, Siemens, Thermo Fisher and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/26/2021 PathAI acquires part of Poplar pathology lab Modern Healthcare ... arm of pathology laboratory Poplar Healthcare. PathAI, a Boston-based startup that develops AI software for pathologists, is one of the most well-funded clinical AI startups. The acquisition marks PathAI's step into traditional clinical diagnostics ; Poplar Healthcare, which is based in Memphis, Tenn., provides testing services for gastroenterologists, dermatologists, oncologists, urologists and gynecologists. Poplar, which will become PathAI's diagnostics division, will be able to use PathAI's machine learning—a ...
7/26/2021 Lab Automation Market Size Worth $8.9 Billion By 2028 | CAGR: 8.1%: Grand View Research, Inc. PR Newswire ... and accuracy obtained through lab automation.Other drivers facilitating growth include smaller volumes of reagents and samples required, personnel safety, progressing drug discovery, miniaturization of the process thus leading to low reagent cost, and clinical diagnostics . The market is anticipated to witness various lucrative opportunities for growth owing to an increasing prevalence of infectious diseases and a rising number of clinical studies which are expected to increase the number of ...
7/26/2021 Lab Automation Market Size Worth $8.9 Billion By 2028 | CAGR: 8.1%: Grand View Research, Inc. Yahoo News ... lab automation.Grand View Research Logo Other drivers facilitating growth include smaller volumes of reagents and samples required, personnel safety, progressing drug discovery, miniaturization of the process thus leading to low reagent cost, and clinical diagnostics . The market is anticipated to witness various lucrative opportunities for growth owing to an increasing prevalence of infectious diseases and a rising number of clinical studies which are expected to increase the number of ...
7/26/2021 Lab Automation Market Size Worth $8.9 Billion By 2028 | CAGR: 8.1%: Grand View Research, Inc. Yahoo News ... lab automation.Grand View Research Logo Other drivers facilitating growth include smaller volumes of reagents and samples required, personnel safety, progressing drug discovery, miniaturization of the process thus leading to low reagent cost, and clinical diagnostics . The market is anticipated to witness various lucrative opportunities for growth owing to an increasing prevalence of infectious diseases and a rising number of clinical studies which are expected to increase the number of ...
7/26/2021 Nuveen Asset Management LLC Takes $17.03 Million Position in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) - Transcript Daily transcriptdaily.com Nuveen Asset Management LLC purchased a new position in shares of Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 882,682 shares of the company’s stock, valued at approximately $17,031,000. Nuveen Asset Management LLC owned 0.40% of Ortho Clinical Diagnostics as of its most recent filing with the Securities and Exchange ...
7/26/2021 Nuveen Asset Management LLC Takes $17.03 Million Position in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) American Banking News Nuveen Asset Management LLC purchased a new position in shares of Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 882,682 shares of the company’s stock, valued at approximately $17,031,000. Nuveen Asset Management LLC owned 0.40% of Ortho Clinical Diagnostics as of its most recent filing with the Securities and Exchange ...
7/26/2021 Point72 Asset Management L.P. Makes New Investment in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) - Transcript Daily transcriptdaily.com Point72 Asset Management L.P. purchased a new position in shares of Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 486,700 shares of the company’s stock, valued at approximately $9,391,000. Point72 Asset Management L.P. owned 0.22% of Ortho Clinical Diagnostics as of its most recent filing with the Securities and Exchange Commission ...
7/26/2021 PerkinElmer to buy antibodies maker BioLegend for about $5.3 billion Yahoo News ... reagents and antibodies used in medical research, for about $5.25 billion in a cash-and-stock deal.The deal, the largest ever for PerkinElmer, will allow the company to grow in areas such as clinical diagnostics and food safety testing, the diagnostic company said.PerkinElmer said it has bridge financing from Goldman Sachs Bank USA to cover the cash portion of the transaction. The company said the deal is expected ...
7/26/2021 Point72 Asset Management L.P. Makes New Investment in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) - American Banking News American Banking News Point72 Asset Management L.P. purchased a new position in shares of Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 486,700 shares of the company’s stock, valued at approximately $9,391,000. Point72 Asset Management L.P. owned 0.22% of Ortho Clinical Diagnostics as of its most recent filing with the Securities and Exchange Commission ...
7/26/2021 PathAI enters into clinical diagnostics through acquisition of Poplar Healthcare Management PR Newswire BOSTON and MEMPHIS, Tenn. , July 26, PathAI, a global provider of artificial intelligence-powered technology for pathology, announced their acquisition of Poplar, the management service organization for Poplar Healthcare PLLC, an industry-leading independent anatomic pathology laboratory services provider."Our mission at PathAI is to improve patient outcomes with AI-powered pathology and the investment in Poplar allows us to advance that mission by enhancing our ability to provide pathologists ...
7/26/2021 Beckman Coulter to Distribute BNP Cardiac Assay to Customers PR Newswire BREA, Calif. Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain all rights related to the manufacture, distribution, and sale of a BNP assay for Beckman Coulter analyzers. Under the terms of the agreements, Quidel will continue to manufacture and supply certain components to Beckman Coulter related to the assay, and Beckman Coulter will exclusively manufacture and sell ...
7/6/2021 Amalgamated Bank Sells 1,002 Shares of FibroGen, Inc. (NASDAQ:FGEN) | Daily Political Daily Political IDEXX Laboratories ( NASDAQ:IDXX ) and Ortho Clinical Diagnostics ( NASDAQ:OCDX ) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation. Analyst Recommendations This is a breakdown of current ratings and recommmendations for IDEXX Laboratories and Ortho Clinical Diagnostics , as provided by MarketBeat.com. IDEXX Laboratories presently has a consensus ...
7/6/2021 IDEXX Laboratories (NASDAQ:IDXX) and Ortho Clinical Diagnostics (NASDAQ:OCDX) Head to Head Analysis - Ticker Report Ticker Report IDEXX Laboratories ( NASDAQ:IDXX ) and Ortho Clinical Diagnostics ( NASDAQ:OCDX ) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.Analyst RatingsGet IDEXX Laboratories alerts: This is a breakdown of current recommendations for IDEXX Laboratories and Ortho Clinical Diagnostics, as provided by MarketBeat.Sell Ratings Hold Ratings ...
7/6/2021 Contrasting Heska (NASDAQ:HSKA) & Ortho Clinical Diagnostics (NASDAQ:OCDX) - American Banking News American Banking News Heska ( NASDAQ:HSKA ) and Ortho Clinical Diagnostics ( NASDAQ:OCDX ) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation. Valuation & Earnings This table compares Heska and Ortho Clinical Diagnostics’ revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per ...
7/6/2021 Contrasting Heska (NASDAQ:HSKA) & Ortho Clinical Diagnostics (NASDAQ:OCDX) dispatchtribunal.com Heska ( NASDAQ:HSKA ) and Ortho Clinical Diagnostics ( NASDAQ:OCDX ) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation. Profitability This table compares Heska and Ortho Clinical Diagnostics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets ...
7/6/2021 Contrasting Heska (NASDAQ:HSKA) & Ortho Clinical Diagnostics (NASDAQ:OCDX) thelincolnianonline.com Heska ( NASDAQ:HSKA ) and Ortho Clinical Diagnostics ( NASDAQ:OCDX ) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, institutional ownership and valuation. Valuation & Earnings This table compares Heska and Ortho Clinical Diagnostics’ revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per ...
7/6/2021 Global Chemistry Analyzers Market Incredible Possibilities, Growth Analysis and Forecast To 2027 pharmanewsdesk.com Academic Research CentersDiagnostic LaboratoriesThe key players operating in Chemistry Analyzers Market such as Beckman Coulter, Abbott Diagnostics, Siemens AG, Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Randox Laboratories Ltd., Roche Diagnostics, ElitechGroup, Mindray, and Horiba.Along with this, the research report encompasses comprehensive information of market leaders that majorly include a business overview, financial overview, product offerings, strategic developments, and geographical presence. The profiled players are collaboratively analyzed for ...
6/30/2021 Blood Transfusion Diagnostics Market Analysis- Size, Share, Sales, Growth, Forecast, Segment, Application Analysis 2020 bigmarketresearch.com ... Under COVID-19 Outbreak, how the Blood Transfusion Diagnostics Blood Transfusion Diagnostics market covered in Chapter 4: Grifols S.A. Bio-rad Laboratories Novartis AG DiaSorin Hologic BAG Health Care Abbott Diagnostics Quidel Corporation Ortho Clinical Diagnostics Becton, Dickinson and Company Immucor Inc. Proteomes Sciences F. Hoffmann-La Roche Beckman Coulter discount/4593208 In Chapter 11 and 13.3, on the basis of types, the Blood Transfusion Diagnostics market from 2015 to ...
6/30/2021 IDEXX Laboratories (NASDAQ:IDXX) & Ortho Clinical Diagnostics (NASDAQ:OCDX) Critical Survey slatersentinel.com 0.29 74.59 IDEXX Laboratories has higher revenue and earnings than Ortho Clinical Diagnostics. Ortho Clinical Diagnostics is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.Institutional & Insider Ownership84.5% of IDEXX Laboratories shares are held by institutional investors. 2.1% of IDEXX Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge ...
6/30/2021 Ortho Clinical Diagnostics (NASDAQ:OCDX) & IDEXX Laboratories (NASDAQ:IDXX) Head-To-Head Survey rivertonroll.com 0 3.00 Ortho Clinical Diagnostics presently has a consensus price target of $24.55, suggesting a potential upside of 13.48%. IDEXX Laboratories has a consensus price target of $474.60, suggesting a potential downside of 25.47%. Given Ortho Clinical Diagnostics’ higher possible upside, research analysts plainly believe Ortho Clinical Diagnostics is more favorable than IDEXX Laboratories.Insider and Institutional Ownership84.5% of IDEXX Laboratories shares are owned by institutional investors ...